Pharmaceutical Pharma companies in developed markets do not consider wholesalers key stakeholders in the delivery of drugs to patients or providers of drug information to physicians. Their added value is not respected thus easily replaced by selling direct to pharmacies, writes P Reed Maurer, long time pharma industry watcher who is president of International Alliances Limited, in his regular exclusive insight for The Pharma Letter. 10 March 2017